Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

AIDS Treatment News Index, 2003

December 26, 2003

2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996

You may find the articles listed below in the AIDS Treatment News Index of Articles, or search The Body.

A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z


Topic Issue #
Abacavir + tenofovir + 3TC failure 393
Abbott raises Norvir price five fold 397
Access for all, Thailand conference theme 395
ADAP organizing 388
ADAP Washington trip 397
Aegis 388
Africa Action 390
Africa trials -- no drugs 391
African-Americans and AIDS Conference 388, 397
AIDS Treatment News online publication 397
AIDS Treatment News 396
Antibiotic-resistant staph 388
Atazanavir (Reyataz) approved 392
Bahamas antiretroviral prices, Clinton 389
Biomedical research cuts 392
Bush AIDS initiative 388, 391
Buyers' club lists 397
Cholesterol management 394
Ciasullo, Eric, on returning to work 395
Clinical Care Options for Hepatitis 391
Clinical Care Options 388
Clinton Foundation lowers Caribbean price 389
Clinton Foundation, HAART 40 cents/day 395
Cohen, Dr. Cal, on Retroviruses conf., pt. 1 389
Cohen, Dr. Cal, on Retroviruses conf., pt. 2 390
Co-trimoxazole for staph 388
Counterfeit Procrit 389
Deep salvage 390
Drug development 397
Efavirenz vs. nevirapine 389
Emtriva (FTC) approved 393
Export problem, WTO 394
Federal policy problems 392
Fosamprenavir approved 395
FTC (Emtriva) approved 393
Fundraising, online 392
FUZEON (T-20) 389
Glaxo research grants 391
Global Fund to Fight AIDS, TB, and Malaria 388
Grassroots organizing 388
Heart disease guidelines 394
Highly experienced patients 390
HIV Insite 388
HIV nutrition info for doctors 391
HIV treatment guidelines, July 393
HIV treatment guidelines, November 2003 396
HIVandHepatitis.com 388
Hoffmann-La Roche, T-20 389
Huge price variations in generics 391
IAS conference reports on Web 393
International AIDS Society conf., Paris 392
Lexiva (908, Fosamprenavir) 389
Lexiva approved 395
Medicaid cuts planned 390
Medicaid organizing 388
Medscape 388
Microbicides 391
MRSA 388
NATAP 388
Nelson Mandela on HIV treatment access 393
Neuropathy treatment, new guidelines 396
Nevirapine reduced maternal transmission 394
Nevirapine toxicity 389
Nevirapine vs. efavirenz 389
Norvir price fivefold rise 397
Paris conference reports on Web 393
Pediatric HIV guidelines, November 2003 396
Pharmaceutical company lobbying facts 397
Pharmacy benefits managers, profit 391
Philadelphia FIGHT 391
Planetwork conference 392
Pneumocystis still cause of death in U.S. 391
Prevention policy problems 392
Prices of drugs 391
Prison Health News 390
Prison skin infections 388
Retroviruses conference, Web coverage 388
Returning to work after disability 395
Reyataz approved 392
Safety net failure 391
SARS Web information 390
Save ADAP committee 397
Search for a Cure, clinical trials forum 395
Social network software, for fundraising 392
Social Security disability definition 392
Staph infection treatments 388
Starting antiretroviral therapy 389
Subscriptions to share 396
T-20 cost 389
TAC (Treatment Action Campaign) 390
Tenofovir + ddI + 3TC failure 395
Thailand conference 2004, deadlines 395
The Body Web site 388
Treatment Action Campaign 390
Treatment interruption 390, 394
Triglycerides management 394
Trizivir arm stopped in trial 390
UNAIDS report for 2003 396
VaxGen's AIDSVAX trial 389
World AIDS: $4.7 billion -- WorldCom: $35 billion 396
World Trade Organization rules 394
WORLD, women and HIV 391
WTO rules limit access to poor countries 394

Advertisement

ISSN # 1052-4207

Copyright 2003 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.




  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by AIDS Treatment News. It is a part of the publication AIDS Treatment News.
 

Tools
 

Advertisement